S100A6-ERBB3 Fusion FISH Probe
The S100A6-ERBB3 Fusion FISH Probe is used to confirm a fusion of the S100A6 and ERBB3 genes. The fusion of the S100A6 and ERBB3 genes has been associated with Pancreatic Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| S100A6-ERBB3-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-RERE | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-REOR | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-REGO | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-REGR | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-OROR | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-GORE | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-GROR | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| S100A6-ERBB3-20-AQAQ | 20 (40 μL) | 200 μL |
|
ERBB3 Gene Summary
This gene encodes a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. This membrane-bound protein has a neuregulin binding domain but not an active kinase domain. It therefore can bind this ligand but not convey the signal into the cell through protein phosphorylation. However, it does form heterodimers with other EGF receptor family members which do have kinase activity. Heterodimerization leads to the activation of pathways which lead to cell proliferation or differentiation. Amplification of this gene and/or overexpression of its protein have been reported in numerous cancers, including prostate, bladder, and breast tumors. Alternate transcriptional splice variants encoding different isoforms have been characterized. One isoform lacks the intermembrane region and is secreted outside the cell. This form acts to modulate the activity of the membrane-bound form. Additional splice variants have also been reported, but they have not been thoroughly characterized. [provided by RefSeq, Jul 2008]
Gene Name: Erb-b2 Receptor Tyrosine Kinase 3
Chromosome: CHR12: 56473808 -56497291
Locus: 12q13.2
S100A6 Gene Summary
The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein may function in stimulation of Ca2+-dependent insulin release, stimulation of prolactin secretion, and exocytosis. Chromosomal rearrangements and altered expression of this gene have been implicated in melanoma. [provided by RefSeq, Jul 2008]
Gene Name: S100 Calcium Binding Protein A6
Chromosome: CHR1: 153507075 -153508717
Locus: 1q21.3
Gene Diseases
The S100A6 ERBB3 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Pancreatic Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|